193 related articles for article (PubMed ID: 29748539)
1. SIRT1 activation with neuroheal is neuroprotective but SIRT2 inhibition with AK7 is detrimental for disconnected motoneurons.
Romeo-Guitart D; Leiva-Rodríguez T; Espinosa-Alcantud M; Sima N; Vaquero A; Domínguez-Martín H; Ruano D; Casas C
Cell Death Dis; 2018 May; 9(5):531. PubMed ID: 29748539
[TBL] [Abstract][Full Text] [Related]
2. Novel neuroprotective therapy with NeuroHeal by autophagy induction for damaged neonatal motoneurons.
Romeo-Guitart D; Marcos-DeJuana C; Marmolejo-Martínez-Artesero S; Navarro X; Casas C
Theranostics; 2020; 10(11):5154-5168. PubMed ID: 32308774
[No Abstract] [Full Text] [Related]
3. Sirtuin 2 Inhibition Attenuates Sevoflurane-Induced Learning and Memory Deficits in Developing Rats via Modulating Microglial Activation.
Wu Z; Zhang Y; Zhang Y; Zhao P
Cell Mol Neurobiol; 2020 Apr; 40(3):437-446. PubMed ID: 31713761
[TBL] [Abstract][Full Text] [Related]
4. SIRT2 Inhibition Improves Functional Motor Recovery After Peripheral Nerve Injury.
Romeo-Guitart D; Leiva-Rodríguez T; Casas C
Neurotherapeutics; 2020 Jul; 17(3):1197-1211. PubMed ID: 32323205
[TBL] [Abstract][Full Text] [Related]
5. Review of the anti-inflammatory effect of SIRT1 and SIRT2 modulators on neurodegenerative diseases.
Zhang Y; Anoopkumar-Dukie S; Arora D; Davey AK
Eur J Pharmacol; 2020 Jan; 867():172847. PubMed ID: 31812544
[TBL] [Abstract][Full Text] [Related]
6. Improved Motor Nerve Regeneration by SIRT1/Hif1a-Mediated Autophagy.
Romeo-Guitart D; Leiva-Rodriguez T; Forés J; Casas C
Cells; 2019 Oct; 8(11):. PubMed ID: 31671642
[TBL] [Abstract][Full Text] [Related]
7. SIRT1 and SIRT2 inhibition impairs pediatric soft tissue sarcoma growth.
Ma L; Maruwge W; Strambi A; D'Arcy P; Pellegrini P; Kis L; de Milito A; Lain S; Brodin B
Cell Death Dis; 2014 Oct; 5(10):e1483. PubMed ID: 25341037
[TBL] [Abstract][Full Text] [Related]
8. Differential sirtuin expression patterns in amyotrophic lateral sclerosis (ALS) postmortem tissue: neuroprotective or neurotoxic properties of sirtuins in ALS?
Körner S; Böselt S; Thau N; Rath KJ; Dengler R; Petri S
Neurodegener Dis; 2013; 11(3):141-52. PubMed ID: 22796962
[TBL] [Abstract][Full Text] [Related]
9. SIRT1 and SIRT2: emerging targets in neurodegeneration.
Donmez G; Outeiro TF
EMBO Mol Med; 2013 Mar; 5(3):344-52. PubMed ID: 23417962
[TBL] [Abstract][Full Text] [Related]
10. Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients.
Grbesa I; Pajares MJ; Martínez-Terroba E; Agorreta J; Mikecin AM; Larráyoz M; Idoate MA; Gall-Troselj K; Pio R; Montuenga LM
PLoS One; 2015; 10(4):e0124670. PubMed ID: 25915617
[TBL] [Abstract][Full Text] [Related]
11. 3-(N-arylsulfamoyl)benzamides, inhibitors of human sirtuin type 2 (SIRT2).
Choi SH; Quinti L; Kazantsev AG; Silverman RB
Bioorg Med Chem Lett; 2012 Apr; 22(8):2789-93. PubMed ID: 22446090
[TBL] [Abstract][Full Text] [Related]
12. Alterations in neuronal survival and glial reactions after axotomy by ceftriaxone and minocycline in the mouse hypoglossal nucleus.
Yamada J; Jinno S
Neurosci Lett; 2011 Oct; 504(3):295-300. PubMed ID: 21970974
[TBL] [Abstract][Full Text] [Related]
13. The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson's disease but not amyotrophic lateral sclerosis and cerebral ischemia.
Chen X; Wales P; Quinti L; Zuo F; Moniot S; Herisson F; Rauf NA; Wang H; Silverman RB; Ayata C; Maxwell MM; Steegborn C; Schwarzschild MA; Outeiro TF; Kazantsev AG
PLoS One; 2015; 10(1):e0116919. PubMed ID: 25608039
[TBL] [Abstract][Full Text] [Related]
14. NeuroHeal Treatment Alleviates Neuropathic Pain and Enhances Sensory Axon Regeneration.
Romeo-Guitart D; Casas C
Cells; 2020 Mar; 9(4):. PubMed ID: 32230770
[TBL] [Abstract][Full Text] [Related]
15. Tissue-specific deregulation of selected HDACs characterizes ALS progression in mouse models: pharmacological characterization of SIRT1 and SIRT2 pathways.
Valle C; Salvatori I; Gerbino V; Rossi S; Palamiuc L; René F; Carrì MT
Cell Death Dis; 2014 Jun; 5(6):e1296. PubMed ID: 24946089
[TBL] [Abstract][Full Text] [Related]
16. Blocking sirtuin 1 and 2 inhibits renal interstitial fibroblast activation and attenuates renal interstitial fibrosis in obstructive nephropathy.
Ponnusamy M; Zhou X; Yan Y; Tang J; Tolbert E; Zhao TC; Gong R; Zhuang S
J Pharmacol Exp Ther; 2014 Aug; 350(2):243-56. PubMed ID: 24833701
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and structure-activity relationship studies of novel sirtuin 2 (SIRT2) inhibitors with a benzamide skeleton.
Sakai T; Matsumoto Y; Ishikawa M; Sugita K; Hashimoto Y; Wakai N; Kitao A; Morishita E; Toyoshima C; Hayashi T; Akiyama T
Bioorg Med Chem; 2015 Jan; 23(2):328-39. PubMed ID: 25515955
[TBL] [Abstract][Full Text] [Related]
18. Sirt2 deacetylase is a novel AKT binding partner critical for AKT activation by insulin.
Ramakrishnan G; Davaakhuu G; Kaplun L; Chung WC; Rana A; Atfi A; Miele L; Tzivion G
J Biol Chem; 2014 Feb; 289(9):6054-66. PubMed ID: 24446434
[TBL] [Abstract][Full Text] [Related]
19. Hit-to-lead optimization on aryloxybenzamide derivative virtual screening hit against SIRT.
Yagci S; Gozelle M; Kaya SG; Ozkan Y; Aksel AB; Bakar-Ates F; Dundar Y; Eren G
Bioorg Med Chem; 2021 Jan; 30():115961. PubMed ID: 33360574
[TBL] [Abstract][Full Text] [Related]
20. Expression/localization patterns of sirtuins (SIRT1, SIRT2, and SIRT7) during progression of cervical cancer and effects of sirtuin inhibitors on growth of cervical cancer cells.
Singh S; Kumar PU; Thakur S; Kiran S; Sen B; Sharma S; Rao VV; Poongothai AR; Ramakrishna G
Tumour Biol; 2015 Aug; 36(8):6159-71. PubMed ID: 25794641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
